NCT03366207View on ClinicalTrials.gov

Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

October 26, 2018

Conditions
UTI - Lower Urinary Tract InfectionAntibiotic Resistant Infection
Interventions
DRUG

Ciprofloxacin

Ciprofloxacin 250 mg PO twice daily (BID) x 3 days for women with uUTI.

Trial Locations (1)

27518

Restore Clinical Research, Cary

Sponsors
All Listed Sponsors
lead

Iterum Therapeutics, International Limited

INDUSTRY